eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironment

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKarakas, Didem
dc.contributor.authorAshour, Ahmed
dc.contributor.authorMokhlis, Hamada Ahmed
dc.contributor.authorKahraman, Nermin
dc.contributor.authorBayraktar, Recep
dc.contributor.authorDilmac, Sayra
dc.contributor.authorKabil, Nashwa N.
dc.contributor.authorErdogan, Mumin Alper
dc.contributor.authorDere, Egemen
dc.contributor.authorUlukaya, Engin
dc.contributor.authorOzpolat, Bulent
dc.date.accessioned2025-10-16T15:11:38Z
dc.date.issued2025
dc.identifier.doi10.1038/s41419-025-07803-w
dc.identifier.otherWOS:001524040400004
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/4881
dc.publisherSPRINGERNATURE
dc.sourceCELL DEATH \& DISEASE
dc.titleeEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironment
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS